[96a5a0]: / output / allTrials / identified / NCT03322020_identified.json

Download this file

371 lines (371 with data), 15.3 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
{
"info": {
"nct_id": "NCT03322020",
"official_title": "Androgen Deprivation Therapy, External Beam Radiotherapy and Stereotactic Radiosurgery Boost for Men With Intermediate- or High-risk Prostate Cancer",
"inclusion_criteria": "* Pathologically confirmed intermediate- or high-risk prostate cancer within 6 months after enrollment\n* ECOG performance status 0-1\n* Appropriate values of blood tests within 6 months after enrollment Absolute neutrophil count (ANC) ≥ 1500 cells/mm3 Platelets ≥ 50,000 cells/mm3 Hemoglobin ≥ 8.0 g/dl\n* Appropriate values of kidney function within 6 months after enrollment Creatinine < 2.0 ng/dL\n* Appropriate values of liver function within 6 months after enrollment total bilirubin < 1.5 X maximum normal value alanine aminotransferase or aspartate aminotransferase < 2.5 X maximum normal value\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 20 Years",
"exclusion_criteria": "* Presence of distant metastasis\n* Presence of pelvic LN metastasis\n* History of androgen deprivation therapy within 6 months after enrollment\n* History of definitive treatment for prostate cancer (e.g., radical prostatectomy)\n* History of pelvic irradiation\n* Double primary cancer other than skin/thyroid cancer",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Pathologically confirmed intermediate- or high-risk prostate cancer within 6 months after enrollment",
"criterions": [
{
"exact_snippets": "Pathologically confirmed intermediate- or high-risk prostate cancer",
"criterion": "prostate cancer risk level",
"requirements": [
{
"requirement_type": "confirmation",
"expected_value": "pathologically confirmed"
},
{
"requirement_type": "risk level",
"expected_value": [
"intermediate",
"high"
]
}
]
},
{
"exact_snippets": "within 6 months after enrollment",
"criterion": "time since enrollment",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 6,
"unit": "months"
}
]
}
}
]
}
]
},
{
"line": "* ECOG performance status 0-1",
"criterions": [
{
"exact_snippets": "ECOG performance status 0-1",
"criterion": "ECOG performance status",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 1,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "* Appropriate values of blood tests within 6 months after enrollment Absolute neutrophil count (ANC) ≥ 1500 cells/mm3 Platelets ≥ 50,000 cells/mm3 Hemoglobin ≥ 8.0 g/dl",
"criterions": [
{
"exact_snippets": "Absolute neutrophil count (ANC) ≥ 1500 cells/mm3",
"criterion": "absolute neutrophil count (ANC)",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1500,
"unit": "cells/mm3"
}
}
]
},
{
"exact_snippets": "Platelets ≥ 50,000 cells/mm3",
"criterion": "platelets",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 50000,
"unit": "cells/mm3"
}
}
]
},
{
"exact_snippets": "Hemoglobin ≥ 8.0 g/dl",
"criterion": "hemoglobin",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 8.0,
"unit": "g/dl"
}
}
]
}
]
},
{
"line": "* Appropriate values of kidney function within 6 months after enrollment Creatinine < 2.0 ng/dL",
"criterions": [
{
"exact_snippets": "Appropriate values of kidney function",
"criterion": "kidney function",
"requirements": [
{
"requirement_type": "timing",
"expected_value": "within 6 months after enrollment"
}
]
},
{
"exact_snippets": "Creatinine < 2.0 ng/dL",
"criterion": "creatinine level",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 2.0,
"unit": "ng/dL"
}
}
]
}
]
},
{
"line": "* Appropriate values of liver function within 6 months after enrollment total bilirubin < 1.5 X maximum normal value alanine aminotransferase or aspartate aminotransferase < 2.5 X maximum normal value",
"criterions": [
{
"exact_snippets": "liver function within 6 months after enrollment",
"criterion": "liver function",
"requirements": [
{
"requirement_type": "time frame",
"expected_value": "within 6 months after enrollment"
}
]
},
{
"exact_snippets": "total bilirubin < 1.5 X maximum normal value",
"criterion": "total bilirubin",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 1.5,
"unit": "X maximum normal value"
}
}
]
},
{
"exact_snippets": "alanine aminotransferase or aspartate aminotransferase < 2.5 X maximum normal value",
"criterion": "alanine aminotransferase or aspartate aminotransferase",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 2.5,
"unit": "X maximum normal value"
}
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be MALE",
"criterions": [
{
"exact_snippets": "Must be MALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "male"
}
]
}
]
},
{
"line": "Must have minimum age of 20 Years",
"criterions": [
{
"exact_snippets": "minimum age of 20 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 20,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Presence of distant metastasis",
"criterions": [
{
"exact_snippets": "Presence of distant metastasis",
"criterion": "distant metastasis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Presence of pelvic LN metastasis",
"criterions": [
{
"exact_snippets": "Presence of pelvic LN metastasis",
"criterion": "pelvic LN metastasis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* History of androgen deprivation therapy within 6 months after enrollment",
"criterions": [
{
"exact_snippets": "History of androgen deprivation therapy within 6 months after enrollment",
"criterion": "androgen deprivation therapy",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
},
{
"requirement_type": "timeframe",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
]
}
]
},
{
"line": "* History of definitive treatment for prostate cancer (e.g., radical prostatectomy)",
"criterions": [
{
"exact_snippets": "History of definitive treatment for prostate cancer",
"criterion": "definitive treatment for prostate cancer",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "radical prostatectomy",
"criterion": "radical prostatectomy",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
},
{
"line": "* History of pelvic irradiation",
"criterions": [
{
"exact_snippets": "History of pelvic irradiation",
"criterion": "pelvic irradiation",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
},
{
"line": "* Double primary cancer other than skin/thyroid cancer",
"criterions": [
{
"exact_snippets": "Double primary cancer",
"criterion": "double primary cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "other than skin/thyroid cancer",
"criterion": "skin/thyroid cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}